Absher Wealth Management, LLC Biogen Inc. Transaction History

Absher Wealth Management, LLC

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2021 Jan 18, 2022	SELL	$223.92 - $287.77 $515,911 - $663,022	-2,304 Closed	0 $0
Q3 2021 Nov 04, 2021	BUY	$282.99 - $369.05 $35,939 - $46,869	127 Added 5.83%	2,304 $652,000
Q2 2021 Aug 03, 2021	BUY	$259.0 - $414.71 $60,347 - $96,627	233 Added 11.99%	2,177 $754,000
Q1 2021 May 07, 2021	BUY	$242.95 - $284.63 $84,060 - $98,481	346 Added 21.65%	1,944 $544,000
Q4 2020 Feb 01, 2021	SELL	$236.26 - $355.63 $112,223 - $168,924	-475 Reduced 22.91%	1,598 $391,000

Q3 2020 Nov 13, 2020	BUY	$264.77 - $305.71 $5,560 - $6,419	21 Added 1.02%	2,073 $588,000
Q2 2020 Jul 27, 2020	BUY	$258.66 - $342.55 $22,762 - $30,144	88 Added 4.48%	2,052 $549,000
Q1 2020 May 01, 2020	BUY	$268.85 - $341.04 $4,570 - $5,797	17 Added 0.87%	1,964 $621,000
Q4 2019 Feb 10, 2020	BUY	$220.06 - $304.07 $428,456 - $592,024	1,947 New	1,947 $549,000

1,048

126M

1.37M

1.35M

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $30.4B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

Get notified when there are updates to the investment portfolio of Absher Wealth Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Absher Wealth Management, LLC with notifications on news.